Parallax Volatility Advisers’s Array Biopharma Inc ARRY Stock Holding History

Parallax Volatility Advisers’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,000	Closed	-$695K	–	3922
2019 Q2	$695K	Buy	+15,000	New	+$421K	﹤0.01%	1407
2017 Q4	–	Sell	-35,000	Closed	-$431K	–	5290
2017 Q3	$431K	Buy	+35,000	New	+$325K	﹤0.01%	1293
2016 Q4	–	Sell	-150,000	Closed	-$1.01M	–	4563
2016 Q3	$1.01M	Sell	150,000 -90,000	-38%	-$348K	﹤0.01%	1249
2016 Q2	$854K	Sell	240,000 -857,500	-78%	-$2.79M	﹤0.01%	1254
2016 Q1	$3.24M	Buy	1,097,500 +467,500	+74%	+$1.4M	0.01%	722
2015 Q4	$2.66M	Buy	630,000 +430,000	+215%	+$1.96M	0.01%	913
2015 Q3	$912K	Hold	200,000	–	–	﹤0.01%	1322
2015 Q2	$1.44M	Buy	+200,000	New	+$1.48M	﹤0.01%	1204

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Parallax Volatility Advisers's ARRY Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 42 shares — an estimated $2K sold.

Parallax Volatility Advisers first reported a position in ARRY in Q2 2015 and held it in 10 quarters. The position peaked at $2.49M in Q4 2015. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Parallax Volatility Advisers reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 42 Array Biopharma Inc shares in Q3 2019, an estimated $2K.
Parallax Volatility Advisers first reported a position in Array Biopharma Inc in Q2 2015 and held it in 10 quarters.
Parallax Volatility Advisers's Array Biopharma Inc position peaked at $2.49M in Q4 2015.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.